Teva Pharma (TEVA) February 12 calls active into quarter results and outlook

Teva Pharma (NYSE: TEVA) February weekly call option implied volatility is at 112, February is at 97; compared to its 52-week range of 25 to 53 into the expected release of quarter results before the bell on January 31. Call put ratio 27 calls to 1 put with focus on February 12 calls.

You May Also Be Interested In

• Carnival Corp. (CCL) call put ratio 3.9 calls to 1 put with a focus on 1600 contracts of October 2 weekly 24 calls into quarter results
• Twilio (TWLO) call put ratio 1 call to 3.7 puts with a focus on October 290 and 295 puts as share price down 6.3%
• Nike (NKE) calls more active than puts into upcoming quarter results